First Allied Advisory Services’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

First Allied Advisory Services’s Portfolio XPH Stock Details XPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-17,679	Closed	-$862K	–	1206
2018 Q3	$862K	Buy	+17,679	New	+$838K	0.03%	515
2016 Q4	–	Sell	-13,200	Closed	-$583K	–	1174
2016 Q3	$583K	Sell	13,200 -515	-4%	-$23.4K	0.03%	518
2016 Q2	$570K	Sell	13,715 -354	-3%	-$15K	0.03%	505
2016 Q1	$564K	Hold	14,069	–	–	0.03%	511
2015 Q4	$715K	Sell	14,069 -6,275	-31%	-$320K	0.04%	460
2015 Q3	$958K	Buy	20,344 +590	+3%	+$35.5K	0.05%	359
2015 Q2	$1.22M	Buy	19,754 +938	+5%	+$58.4K	0.05%	349
2015 Q1	$1.16M	Buy	18,816 +12,506	+198%	+$742K	0.08%	308
2014 Q4	$342K	Sell	6,310 -11,388	-64%	-$622K	0.02%	685
2014 Q3	$938K	Buy	17,698 +566	+3%	+$28.8K	0.07%	308
2014 Q2	$887K	Buy	17,132 +3,330	+24%	+$161K	0.07%	352
2014 Q1	$644K	Buy	13,802 +7,364	+114%	+$348K	0.05%	436
2013 Q4	$282K	Buy	+6,438	New	+$268K	0.02%	684

Other funds holding XPH

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Baird Financial Group Milwaukee, Wisconsin $64B AUM 22.64% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return

HCIA

Hochman Cole Investment Advisors Deerfield, Illinois $255M AUM 23.27% 1-Year Est. Return

First Allied Advisory Services's XPH Position: Q4 2018 in Review

First Allied Advisory Services sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q4 2018, closing a stake of 17,679 shares — an estimated $862K sold.

First Allied Advisory Services first reported a position in XPH in Q4 2013 and held it in 13 quarters. The position peaked at $1.22M in Q2 2015. 74 funds tracked by Wall St. Rank hold XPH as of Q4 2018.

First Allied Advisory Services reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q4 2018 after selling out during the quarter.
First Allied Advisory Services sold 17,679 State Street SPDR S&P Pharmaceuticals ETF shares in Q4 2018, an estimated $862K.
First Allied Advisory Services first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q4 2013 and held it in 13 quarters.
First Allied Advisory Services's State Street SPDR S&P Pharmaceuticals ETF position peaked at $1.22M in Q2 2015.
74 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q4 2018.

Based on First Allied Advisory Services's 13F filing for Q4 2018, filed 15 Feb 2019.